Based on these findings, CD47 has become an attractive target for cancer therapy, and several studies have now confirmed the antitumor efficacy of its blockade,23, 24, 25, 26 which not only promotes tumor cell clearance by macrophages and DC but also supports therapeutic regimens linked to adaptive antitumor immunity.27 Here, CD47 is linked to neoplasm.